Pharsight

1. Otiprio patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9603796	ALK ABELLO	Controlled release antimicrobial compositions and methods for the treatment of otic disorders	Apr, 2029 (5 years from now)
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9205048	ALK ABELLO	Controlled release antimicrobial compositions and methods for the treatment of otic disorders	Apr, 2029 (5 years from now)
US11369566	ALK ABELLO	Controlled release antimicrobial compositions and methods for the treatment of otic disorders	Apr, 2029 (5 years from now)
US9233068	ALK ABELLO	Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders	Dec, 2029 (6 years from now)
US8318817	ALK ABELLO	Controlled release antimicrobial compositions and methods for the treatment of otic disorders	Apr, 2030 (6 years from now)
US9220796	ALK ABELLO	Sterilization of ciprofloxacin composition	Jul, 2035 (11 years from now)
US11040004	ALK ABELLO	Otic gel formulations for treating otitis externa	Nov, 2037 (14 years from now)
US11246863	ALK ABELLO	Ciprofloxacin otic composition and kits and method for using same	Nov, 2038 (15 years from now)

Drugs and Companies using CIPROFLOXACIN ingredient

Market Authorisation Date: 10 December, 2015

Treatment: Treatment of pediatric patients with otitis media with effusion undergoing tympanostomy tube placement; Treatment of otic infection or inflammation; The treatment of acute otitis externa in patients 6...

Dosage: INJECTABLE, SUSPENSION;OTIC